Predicción y previsión de precio de Virax Biolabs Group Ltd (VRAX)VRAXVirax Biolabs Group Ltd

Alphio's VRAX stock price prediction model matches the current Virax Biolabs Group Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.85 (+1.09%). The 1-week path is $3.15 (+11.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Virax Biolabs Group Ltd (VRAX) is not a strong buy due to its significant year-to-date decline of 70.62% and a negative forward P/E ratio of 0, indicating potential challenges in future earnings. The RSI is at 42.168, suggesting the stock is nearing oversold conditions, but the recent 5-day change of -11.60% raises concerns about short-term momentum. The main risk is its low trading volume of 37,110 compared to an average of 1,008,051, indicating a lack of investor interest and liquidity.

Virax Biolabs Group Ltd (VRAX) last closed at $2.82, losing -4.08%. These facts feed the 1-day and 1-week VRAX price prediction above.